Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Identification of antigen-specific TCR sequences based on biological and statistical enrichment in unselected individuals
Neal P. Smith, … , J. Christopher Love, Wayne G. Shreffler
Neal P. Smith, … , J. Christopher Love, Wayne G. Shreffler
Published May 25, 2021
Citation Information: JCI Insight. 2021;6(13):e140028. https://doi.org/10.1172/jci.insight.140028.
View: Text | PDF
Resource and Technical Advance Immunology

Identification of antigen-specific TCR sequences based on biological and statistical enrichment in unselected individuals

  • Text
  • PDF
Abstract

Recent advances in high-throughput T cell receptor (TCR) sequencing have allowed for new insights into the human TCR repertoire. However, methods for capturing antigen-specific repertoires remain an area of development. Here, we describe a potentially novel approach that utilizes both a biological and statistical enrichment to define putatively antigen-specific complementarity-determining region 3 (CDR3) repertoires in unselected individuals. The biological enrichment entailed FACS of in vitro antigen-activated memory CD4+ T cells, followed by TCRβ sequencing. The resulting TCRβ sequences were then filtered by selecting those that are statistically enriched when compared with their frequency in the autologous resting T cell compartment. Applying this method to define putatively peanut protein–specific repertoires in 27 peanut-allergic individuals resulted in a library of 7345 unique CDR3β amino acid sequences that had similar characteristics to other validated antigen-specific repertoires in terms of homology and diversity. In-depth analysis of these CDR3βs revealed 36 public sequences that demonstrated high levels of convergent recombination. In a network analysis, the public CDR3βs were shown to be core sequences with more edges than their private counterparts. This method has the potential to be applied to a wide range of T cell–mediated disorders and to yield new biomarkers and biological insights.

Authors

Neal P. Smith, Bert Ruiter, Yamini V. Virkud, Ang A. Tu, Brinda Monian, James J. Moon, J. Christopher Love, Wayne G. Shreffler

×

Figure 2

Putatively peanut-specific CDR3β sequences demonstrate increased similarity and decreased diversity when compared with total activated and resting CDR3βs.

Options: View larger image (or click on image) Download as PowerPoint
Putatively peanut-specific CDR3β sequences demonstrate increased similar...
(A and B) Minimum Hamming and Levenshtein distance of putatively peanut-specific CDR3β sequences (ps-CDR3s) compared with 100 equal-sized random resamplings of total activated and resting CDR3βs (**P < 0.01, ps-CDR3 vs. resting and ps-CDR3 vs. activated, Fisher’s exact test). (C) Smoothed Hill’s diversity curve at diversity orders 0–4 for 6 individuals. Diversity of ps-CDR3s was significantly lower than that of activated and resting CDR3βs at all diversity orders (P < 0.01, empirical cumulative distribution function of bootstrap delta distribution, see Methods). (D) Fold change of Hill’s diversity metric of resting/ps-CDR3s, activated/ps-CDR3s, and resting/activated CDR3βs. Distributions represent values from 25 individuals with >30 unique ps-CDR3s (**P < 0.01, Wilcoxon matched-pairs signed-rank test).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts